Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
FL-115 in Non-Muscle Invasive Bladder Neoplasms: NCT07122414 Clinical Landscape Report 2026
15 October 2026
NCT07122414 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
γδ T Cell(Guangzhou Bio-gene Technology) in Acute Myeloid Leukemia: NCT07123662 Clinical Landscape Report 2026
15 October 2026
NCT07123662 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CS-32582 in Plaque psoriasis: NCT07129382 Clinical Landscape Report 2026
15 October 2026
NCT07129382 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Medroxyprogesterone Acetate in Nausea: NCT07124195 Clinical Landscape Report 2026
15 October 2026
NCT07124195 clinical landscape for Nausea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GT-719 in Scleroderma, Diffuse: NCT07122076 Clinical Landscape Report 2026
15 October 2026
NCT07122076 clinical landscape for Scleroderma, Diffuse: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Bladder Cancer: NCT07129993 Clinical Landscape Report 2026
15 October 2026
NCT07129993 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Allogeneic γδ T Cells(Hematology Hospital of Chinese Academy of Medical Sciences) in Acute Myeloid Leukemia: NCT07126782 Clinical Landscape Report 2026
15 October 2026
NCT07126782 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Olutasidenib in Acute Myeloid Leukemia: NCT07130695 Clinical Landscape Report 2026
15 October 2026
NCT07130695 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nomelcitinib in Plaque psoriasis: NCT07130604 Clinical Landscape Report 2026
15 October 2026
NCT07130604 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Adalimumab in Arthritis, Psoriatic: NCT07128472 Clinical Landscape Report 2026
15 October 2026
NCT07128472 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07132684 Clinical Landscape Report 2026
15 October 2026
NCT07132684 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Relapsing acute myeloid leukemia: NCT07131085 Clinical Landscape Report 2026
15 October 2026
NCT07131085 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…